Preserving the Value of Critical Anti-Infectives

Antibiotics R&D

The Rebirth of Antibiotic R&D: New Momentum for an Old Crisis

David Alvaro, Ph.D.

Pharma's Almanac

EU Overhaul

Europe’s Pharma Overhaul: How the New Incentive Model Will Reshape Global Innovation Strategy

David Alvaro, Ph.D.

Pharma's Almanac

Cell Therapy

Building a Better Cell Therapy CDMO

Kincell Bio

Biologics

HIPRA Biotech Services' End-to-End Biologics Offering

HIPRA Biotech Services

Biotech

Australia: Life Sciences' New Frontier

Mark W. Womack

BioCina

Sterile

Expanding Sterile Fill-Finish for the Next Era of Biologics

Afton Scientific

Cell Therapy

How Kincell Bio is Supporting Tomorrow's Cell Therapy Innovators

Mark Bamforth

Kincell Bio

Biomanufacturing

Organoids, ADCs, and More on the Horizon at Samsung Biologics

Kevin Sharp

Samsung Biologics

Biomanufacturing

Exploring Australia's Burgeoning Life Sciences Market with BioCina

Mark W. Womack

BioCina

Automation

3P innovation's Unique Automation Solutions

David Johnson

3P innovation

Advisory

CDMO Advisor is Connecting Innovators with Manufacturers

Bernardo Estupiñán

CDMO Advisor

Legislation

Pharma and Biopharma Outsourcing Association on Advocating for CDMOs

Gil Roth

PBOA - Pharma and Biopharma Outsourcing Association